PCBL Chemical Limited submitted half-yearly reporting details for its listed non-convertible debentures for the period ended September 30, 2026. The filing covers compliance requirements under SEBI regulations for private placement securities.

The submission relates to the debt securities issued through private placement under the SEBI (Issue and Listing of Non-Convertible Securities) Regulations, 2021. PCBL Chemical filed the statement in the prescribed format as per Chapter VIII of the SEBI Master Circular dated October 15, 2025.

Debt securities status

The company disclosed details regarding its outstanding NCDs, including issuance and maturity timelines. The securities carry a fixed coupon rate and are scheduled for annual payment frequency.

Repayment progress

The outstanding amount reflects principal repayments made during the preceding two years. The company noted that a 15% payment was made on each of the two annual dates: January 29, 2025, and January 29, 2026. This indicates a structured amortization schedule reducing the principal liability over the five-year tenor.

The filing was signed by Ravi Varma, Company Secretary and Compliance Officer, and submitted to BSE Limited. Copies were also forwarded to National Securities Depository Limited and Central Depository Services (India) Limited.

PCBL Chemical Limited held its 65th Annual General Meeting on September 22, 2026, where members adopted the audited standalone and consolidated financial statements for FY26 and confirmed the payment of an interim dividend of ₹6.00 per equity share.

The meeting, conducted via Video Conferencing, saw the re-appointment of Chairman Sanjiv Goenka as a Director retiring by rotation. All four resolutions proposed by the Board were passed with requisite majorities, reflecting strong shareholder support for the management's strategic direction and financial performance.

Chairman highlights transformation and new segments

During the address, Chairman Sanjiv Goenka described the previous year as challenging but noted that internal changes are driving better capacity utilization and research outcomes. He emphasized a steady shift in product mix toward value-added specialty blacks and chemicals, which is improving margins despite geopolitical pressures on raw material supplies.

A key focus area highlighted was the battery chemicals plant, which is nearing operational readiness. Products are currently under trial with various consumers, and once fully operational after customer approvals, the segment is expected to be significantly accretive to the bottom line.

Voting results show overwhelming support

The voting process, facilitated by NSDL, recorded high participation with all resolutions passing comfortably. The adoption of financial statements received over 99% support, while the confirmation of the interim dividend saw similar backing.

What the Numbers Show

The voting data reveals a near-unanimous consensus among shareholders regarding the company's strategic pivot. The resolution ratifying the remuneration for Cost Auditors M/s Shome & Banerjee received the highest support at 99.99% in favour, indicating minimal dissent on operational compliance matters. In contrast, the re-appointment of Chairman Sanjiv Goenka attracted the highest dissent rate at 0.38%, though this remains negligible against the total valid votes cast, suggesting that governance concerns are not a primary driver of shareholder sentiment at this juncture.

Member queries focus on ESG and AI integration

Pre-registered members raised questions concerning the company’s growth strategy amidst demand slowdowns linked to geopolitical tensions. Key topics included the impact of supply chain disruptions, plans for entering new segments, and the integration of Environmental, Social, and Governance (ESG) criteria across the value chain. Members also sought updates on Artificial Intelligence integration in business processes, cybersecurity measures, and progress on the Aquapharm business and R&D initiatives.